EUCTR2007-007034-18-DE进行中（未招募）不适用
Phase II-Studie zur Erfassung der Effektivität einer wöchentlich verabreichten Docetaxel-Carboplatin/Cisplatin-Cetuximab-Kombination (DCC) bei fortgeschrittenen Plattenepithelkarzinomen des Oropharynx und der Mundhöhle
Charité Universitätsmedizin Berlin - CVK0 个研究点开始时间: 2008年8月15日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- histologically confirmed relapse or metastasis of an advanced squamaous cell carcinoma in oropharynx or oral cavity
- •- patients with relapse and/or metastasis of the head and neck for whom a local therapy is not indicated
- •- patients with at least one measurable lesion according RECIST-criteria version 1.0
- •- ECOG performace status 0 or 1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- radiotherapy within the last 6 months before screening
- •- systemic chemotherapy apart from radiochemotherapy for local advanced tumor
- •- therapy with antibodies or protein kinase inhibitors
- •- any prior or existing malignancies except SCCHN. Except for basal squamous scell skin cancer and adequately treated carcinoma in situ of the cervix
研究者
相似试验
进行中（未招募）
不适用
Phase II-Studie zur Erfassung der Wirksamkeit einer neoadjuvanten Chemotherapie mit 5-FU/ Leucovorin/ Oxaliplatin/ Docetaxel beim lokal fortgeschrittenen Adenokarzinom des Magens oder des gastroösophagalen Übergangs (FLOT) - NeoFLOT-2-Studielokal fortgeschrittenes Adenokarzinom des Magens oder des gastroösophagalen ÜbergangsMedDRA version: 9.1Level: LLTClassification code 10042090Term: Stomach carcinomaEUCTR2009-012608-20-DEAn-Institut für Qualitätssicherung in der operativen Medizin gGmbH49
进行中（未招募）
1 期
Essai de phase II d’évaluation de l’efficacité et de la tolérance du bevacizumab (AVASTIN®) dans les cancers du sein inflammatoire HER2-. - BEVERLYEUCTR2008-001807-53-FRFédération Nationale des Centres de Lutte100
进行中（未招募）
1 期
Phase II Study for the Evaluation of the Efficacy of Gemcitabine plus Erlotinib in Rash-positive Patients with metastatic pancreatic cancer and good risk factorsmetastatic pancreatic carcinomaMedDRA version: 18.1Level: LLTClassification code 10033576Term: Pancreas carcinomaSystem Organ Class: 100000004864EUCTR2011-005471-17-DEKlinikum der Universität München-Großhadern150
已完成
2 期
The phase II study for evaluating the effectiveness and safety of allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia with FLT3/ITD mutation. -JALSG AML209-FLT3-SCT Study (AML209-FLT3-SCT)Acute myeloid leukemiaJPRN-UMIN000003433Japan adult leukemia study group60
进行中（未招募）
1 期
Estudio de fase II para evaluar la eficacia y la seguridad de la quimiorradioterapia con 5-fluorouracilo, mitomicina C y panitumumab como tratamiento del carcinoma anal de células escamosasEUCTR2010-018430-48-ESGrupo Español Multidisciplinar en cáncer Digestivo-GEMCAD